Advanced Therapies Show Modest Efficacy in IBD-Related PSC

1 source1 article First seen 5 hours ago Updated 5 hours ago United Kingdom Truth score 38

Save Compare coverage

Summary

In patients with inflammatory bowel disease and concurrent primary sclerosing cholangitis, advanced therapies appear modestly effective for remission, as per a meta-analysis of case series. Medscape News UK

Description from Medscape.

Who is covering this

Medscape Center Factuality: Mostly factual US 5 hours ago
Advanced Therapies Show Modest Efficacy in IBD-Related PSC
In patients with inflammatory bowel disease and concurrent primary sclerosing cholangitis, advanced therapies appear modestly effective for remission, as per a meta-analysis of case series. Medscape News UK

Truth score

38/100Weakly supported

Independent outlets: 1
Source reliability: 65/100
Sides of the spectrum covering it: 1/3
Propaganda risk: 0/100

How well the story is corroborated by independent, reliable outlets across the spectrum. Not a fact-check of each claim. How the truth score works

Coverage by lean

Centre 100%100%

Left: 0
Centre: 1
Right: 0
Not rated: 0

How lean is counted

Source quality

Average reliability: 65/100 (Mostly factual)
Low-credibility outlets: 0%
State media: 0%
Opinion pieces: 0%

Where ratings come from

Where the coverage comes from

United States1

In this story

Medscape News

Filter the stories

Sources Ratings and details

Advanced Therapies Show Modest Efficacy in IBD-Related PSC

Summary

Who is covering this

Summary

Who is covering this

Related stories

MPs Have 'No Faith' in Government's Obesity 'Moonshot'

High hsCRP Levels Tied to Worse Outcomes in Kidney Disease

Efgartigimod Adds No Remission Benefit in Pemphigus

Government Reverses Decision to Scrap Healthwatch

GPs Urged Not to Lose the Thread of Continuity in Care

Opportunistic CT Maps Age-Related Bone Density Loss